Statin Therapy

Healio and Cardiology Today have compiled a list of the most-read news of 2022 in CHD and prevention.

The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.

Low-dose statin therapy vs. placebo and six over-the-counter supplements marketed for cholesterol health.

Physician “nudges” via electronic health record prompts and peer comparison feedback improved statin prescription in the primary care setting for eligible patients compared with usual care, researchers reported.

A deep-learning model using information from a single chest X-ray reliably predicted atherosclerotic CVD risk and statin eligibility when compared with a common risk calculator, researchers reported.

In a systemic review and meta-analysis, statin therapy during androgen-ablative therapies was associated with a potential mortality benefit for men being treated for prostate cancer.

Healio and Cardiology Today have compiled a list of the most-read news in cardiology of November 2022.

Vitamin D3 supplementation was not associated with reduced statin-associated muscle symptoms compared with placebo among new statin users enrolled in the VITAL trial, according to a trial subanalysis published in JAMA Cardiology.

Treatment effect of the PCSK9 inhibitor alirocumab (Praluent, Sanofi/Regeneron) vs. sham control on LDL in patients with STEMI referred for primary PCI.

CHICAGO — In this Healio video exclusive, Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, discusses the results of the SPORT late-breaking clinical trial presented at the American Heart Association Scientific Sessions.